Daniel Larcombe-Young

This paper shows that modifying T cells to use fructose via GLUT5 improves their anti-tumor activity in low-glucose environments.

This paper develops hypoxia-sensing CAR T-cells that selectively target solid tumors without off-tumor toxicity using murine xenograft models.